Terminology Service for NFDI4Health
JSON

Gemcitabine-Cisplatin Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C63406

A chemotherapy regimen consisting of gemcitabine hydrochloride and cisplatin used in the treatment of a variety of cancers, including bladder, cervical, pancreatic, ovarian, mesothelioma, and non-small cell lung cancer (NSCLC). [ ]

Term info

Label

Gemcitabine-Cisplatin Regimen

Synonyms
  • GemCis
  • Gemcitabine-Cisplatin
  • Gemcitabine-Cisplatin Regimen
  • Gemcitabine/Cisplatin
  • gemcitabine/cisplatin regimen
Subsets

NCIT_C160952, NCIT_C160950, NCIT_C157711, NCIT_C157712

ALT DEFINITION

A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical cancer, pancreatic cancer, and epithelial ovarian cancer. It is also being studied in the treatment of other types of cancer. It includes the drugs gemcitabine hydrochloride and cisplatin.

DesignNote

Source: NCCN Guidelines 2007 and PDQ, Source: NCCN Guidelines 2007 (Non-Small Cell Lung, Pancreatic and Cervical), Source: Physician's Cancer Chemotherapy Drug Manual 2006 (Ovarian)

Legacy Concept Name

Gemcitabine-Cisplatin_Regimen

Preferred Name

Gemcitabine-Cisplatin Regimen

Semantic Type

Therapeutic or Preventive Procedure

UMLS CUI

C1880939

code

C63406